CD38 and atopic eczema: Previous studies have reported that NMN supplementation decreases ROS levels by inhibiting CD38 expression [26], recruits glutathione to repress skin oxidative damage [39] and improves the symptoms of atopic dermatitis in mice by blocking ROS [40].